On Apr 10, we issued an updated research report on Haemonetics Corporation HAE. The company has been gaining on continued momentum in new business generation and geographical expansion. The stock carries a Zacks Rank #3 (Hold).
Haemonetics Rides High on Plasma, Blood Center Remains Weak
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться